Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment

Hepatology Research

Volumn 39, Issue 3, 2009, Pages 231-240

  Yang, Wei ^a   Chen, Min Hua ^a,b   Wang, Mao Qiang ^a   Cui, Ming ^b   Gao, Wen ^a   Wu, Wei ^a   Wu, Jin Yu ^a   Dai, Ying ^a   Yan, Kun ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Recurrence; Transarterial chemoembolization; Ultrasonography

Indexed keywords

10 HYDROXYCAMPTOTHECIN; CARBOPLATIN; EPIRUBICIN; IODINATED POPPYSEED OIL;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; BONE MARROW DEPRESSION; CANCER SURVIVAL; CAUSE OF DEATH; CHEMOEMBOLIZATION; DRUG EFFICACY; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEMATOTHORAX; HEMOPERITONEUM; HOSPITALIZATION; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT CANCER; RETROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL TIME; TUMOR GROWTH;

EID: 69249212586     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00451.x     Document Type: Article

References (28)

1. Di Bisceglie A, Rustgi V, Hoffnagle J, Dusheiko GM, Lotze MT. NIH conference on hepatocellular carcinoma. Ann Intern Med 1988; 108: 390-401.
2. Ikeda K, Saitoh S, Tsubota A et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71: 19-25.
3. Shuto T, Kinoshita H, Hirohashi K et al. Indications for, and effectiveness of, a second hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 1996; 43: 932-7.
4. Sugima chi K, Maehara S, Tanaka S, Shimada M, Sugimachi K. Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2001; 8: 410-16.
5. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003; 238: 703-10.
6. Yang W, Chen MH, Yin SS et al. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: Therapeutic efficacy on early and late phase recurrence. AJR Am J Roentgenol 2006; 186: S275-283.
7. Choi D, Lim HK, Kim MJ et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004; 230: 135-41.
8. Nicoli N, Casaril A, Marchiori L, Mangiante G, Hasheminia AR. Treatment of recurrent hepatocellular carcinoma by radiofrequency thermal ablation. J Hepatobiliary Pancreat Surg 2001; 8: 417-21.
9. Elias D, de Baere T, Smayra T, Ouellet JF, Roche A, Lasser P. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 2002; 89: 752-6.
10. Poon RT, Ngan H, Lo CM et al. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 2000; 73: 109-14.
11. Okazaki M, Yamasaki S, Ono H et al. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Hepatogastroenterology 1993; 40: 320-3.
12. Farges O, Regimbeau JM, Belghiti J. Aggressive management of recurrence following surgical resection of hepatocellular carcinoma. Hepatogastroenterology 1998; 45 (Suppl 3): 1275-80.
13. Poon RT, Fan ST, Lo CM et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: Long-term results of treatment and prognostic factors. Ann Surg 1999; 229: 216-22.
14. Hu RH, Lee PH, Yu SC et al. Surgical resection for recurrent hepatocellular carcinoma: Prognosis and analysis of risk factors. Surgery 1996; 120: 23-9.
15. Bruix J, Llovet JM, Castells A et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized controlled trial in a single institution. Hepatology 1998; 27: 1578-83.
16. Nakakura E, Choti M. Management of hepatocellular carcinoma. Oncology 2000; 14: 1085-98.
17. Pelletier G, Ducreux M, Gay F et al. Treatment of unresectable Hepatocellular carcinoma with Lipiodol chemoembolization: A multicenter randomized trial. Groupe CHC. J Hepatol 1998; 29: 129-34.
18. Kainuma O, Asanot T, Aoyama H et al. Recurrent hepatocellular carcinoma successfully treated with radiofrequency thermal ablation. J Hepatobiliary Pancreat Surg 1999; 6: 190-4.
19. Cheng B-Q, Jia C-Q, Liu C-T et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm - a randomized controlled trial. JAMA 2008; 299: 1669-77.
20. Bloomston M, Binitie O, Fraiji E et al. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 2002; 68: 827-31.
21. Buscarini L, Buscarini E, Di Stasi M et al. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 1999; 20: 47-53.
22. Yamakado K, Nakatsuka A, Akeboshi M et al. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival. Oncol Rep 2004; 11: 105-9.
23. Yamakado K, Nakatsuka A, Ohmori S et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: Treatment response based on tumor size and morphology. J Vasc Interv Radiol 2002; 13: 1225-32.
24. Kitamoto M, Imagawa M, Yamada H et al. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: Comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol 2003; 181: 997-1003.
25. Chung JW, Park JH, Han JK et al. Hepatic tumors: Predisposing factors for complications of transcatheter oily chemoembolization. Radiology 1996; 198: 33-40.
26. Gasparini D, Sponza M, Marzio A et al. Combined treatment, TACE and RF ablation, in HCC: Preliminary results. Radiol Med 2002; 104: 412-20.
27. Livraghi T, Goldberg SN, Lazzaroni S et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000; 214: 761-8.
28. Chen MH, Yang W, Yan K et al. Large liver tumors: Protocol for radiofrequency ablation and its clinical application in 110 patients - mathematic model, overlapping mode, and electrode placement process. Radiology 2004; 232: 260-71.